Vivozon Healthcare Inc (082800) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Vivozon Healthcare Inc stock KRW 2,179, price KRW 3,000, that is 27.4% below the price, quality 29 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Vivozon Healthcare Inc
082800 · KQExpensive (fair value 27% below the price), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
60‑month range 1,956 KRW – 10,636 KRW · fair‑value band 1,634 KRW – 2,723 KRW · the 3,000 KRW price screens above the 2,179 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether Vivozon Healthcare is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications.
Show moreShow less
It also provides LED set linear lamps, including panel lamps, down lights, and flood lights for residential, commercial, and industrial structures, as well as lights for parking lots.
In addition, the company operates Echo House, a lighting show room that sells LED florescent lamps, LED flat lamps, LED PAR lamps, LED bulb lamps, and home LED lightings.
The company was formerly known as Vivozon Healthcare, Inc. and changed its name to Vivozon Pharmaceutical Co., Ltd. in November 2022. Vivozon Pharmaceutical Co., Ltd. was founded in 2002 and is based in Yongin, South Korea.
Stock analysis
Vivozon Healthcare Inc (082800) currently trades at 3,000 KRW, while our estimate is 2,179 KRW, 27% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: 1,634 KRW (bear) to 2,723 KRW (bull), the price of 3,000 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 29/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Vivozon Healthcare Inc reported revenue of 59.3B KRW in FY2025 versus 57.7B KRW in FY2021, a compound +0.7%/yr. Reported net income was −32.4B KRW in FY2025.
Key figures
Market cap 178B KRW (≈ $133M) Micro · P/S ratio 2.97 · Net margin −127% · Return on equity −1,315% · Return on assets (EBIT) −8.5% (5-year average) · Operating margin −37.7% · Revenue (TTM) 59.9B KRW · Revenue growth (YoY) +8.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 6 out of 100 (low confidence).
What moves the price
The share trades about 48% below its 52-week high and 39% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −38% fair-value upside, at −27%, 082800 screens cheaper than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
082800 screens overvalued: fair value 27% below the price. Compare with ST Pharm Co →
Compare Vivozon Healthcare Inc with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Pharmaceuticals · 58 stocks
Valuation Multiplesvs Pharmaceuticals median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Information Technology sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on assets by industry
- Fair value gap by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: South Korean Stocks
- Valuation of the Korea market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Pharmaceuticals stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Huons Global Co 084110 | 19,430 KRW | 47,019 KRW | +142% | vs 082800 |
| DongKook Pharmaceutical Co 086450 | 23,050 KRW | 28,372 KRW | +23% | vs 082800 |
| VIKRAMTH VIKRAMTH | ₹319.80 | ₹352.17 | +10% | vs 082800 |
| ST Pharm Co 237690 | 71,200 KRW | 61,182 KRW | −14% | vs 082800 |
| Oscotec Inc 039200 | 34,250 KRW | 21,262 KRW | −38% | vs 082800 |
| NatureCell Co 007390 | 21,950 KRW | 11,176 KRW | −49% | vs 082800 |
| Mezzion Pharma Co 140410 | 64,500 KRW | 31,450 KRW | −51% | vs 082800 |
| BINEX Co 053030 | 6,680 KRW | 1,844 KRW | −72% | vs 082800 |
| Caregen Co 214370 | 27,900 KRW | 5,414 KRW | −81% | vs 082800 |
| SHUKRAPHAR SHUKRAPHAR | ₹82.24 | ₹9.14 | −89% | vs 082800 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Vivozon Healthcare Inc (082800) overvalued or undervalued?
What is the fair value of 082800?
What is the quality score of 082800?
What is the price target for Vivozon Healthcare Inc (082800)?
What is the Vivozon Healthcare Inc stock forecast for 2026?
What is the revenue of Vivozon Healthcare Inc (082800)?
What is the intrinsic value of Vivozon Healthcare Inc (082800)?
Is Vivozon Healthcare Inc stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 082800?
How much is Vivozon Healthcare Inc worth?
What do the bullish and bearish scenarios say about 082800?
How far is 082800 from its 52-week high?
Which stocks are comparable to Vivozon Healthcare Inc?
Is Vivozon Healthcare Inc stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Vivozon Healthcare Inc (082800)?
What should I pay attention to with Vivozon Healthcare Inc right now?
Key figures of Vivozon Healthcare Inc
How large is the market capitalisation of Vivozon Healthcare Inc (082800)?
What is the P/S ratio of Vivozon Healthcare Inc (082800)?
What is the net margin of Vivozon Healthcare Inc (082800)?
What is the return on equity of Vivozon Healthcare Inc (082800)?
What is the EBIT return on assets of Vivozon Healthcare Inc (082800)?
What is the operating margin of Vivozon Healthcare Inc (082800)?
How fast is revenue growing at Vivozon Healthcare Inc (082800)?
How much free cash flow does Vivozon Healthcare Inc (082800) generate?
How much net debt does Vivozon Healthcare Inc (082800) carry?
Watch Vivozon Healthcare Inc in the live analysis
One click puts Vivozon Healthcare Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.